01 ReMind-Brain-Health-Product-pill-bottle sm.jpg
02 Remind-Box--Front-ls sm.jpg
03 Remind-Box-Front-RS sm.jpg
01 ReMind-Brain-Health-Product-pill-bottle sm.jpg
02 Remind-Box--Front-ls sm.jpg
03 Remind-Box-Front-RS sm.jpg

Re-Mind

from €47.99
sale

ReMind is a unique Irish patented food supplement combining carotenoids, omega-3s and vitamin E to support the management of Alzheimer's Disease*

  • The identical formulation tested in the Re-MIND Alzheimer’s Clinical Trial

  • 3 small capsules to be taken altogether each day with food

  • No side-effects or contraindications

  • Gluten free and diabetic friendly

  • Supplement Certified - independently tested and verified for ingredient label claim and shelf-life stability

Order Size:
Quantity:
Add To Cart

ReMind is a unique Irish patented food supplement combining carotenoids, omega-3s and vitamin E to support the management of Alzheimer's Disease*

  • The identical formulation tested in the Re-MIND Alzheimer’s Clinical Trial

  • 3 small capsules to be taken altogether each day with food

  • No side-effects or contraindications

  • Gluten free and diabetic friendly

  • Supplement Certified - independently tested and verified for ingredient label claim and shelf-life stability

ReMind is a unique Irish patented food supplement combining carotenoids, omega-3s and vitamin E to support the management of Alzheimer's Disease*

  • The identical formulation tested in the Re-MIND Alzheimer’s Clinical Trial

  • 3 small capsules to be taken altogether each day with food

  • No side-effects or contraindications

  • Gluten free and diabetic friendly

  • Supplement Certified - independently tested and verified for ingredient label claim and shelf-life stability

Re-MIND Alzheimer’s Clinical Trial Findings

  • Early-mid stage Alzheimers patient's were supplemented with omega-3 fish oils (DHA & EPA), carotenoids (lutein, zeaxanthin & meso-zeaxanthin) and vitamin E over a 12 month period.

  • Patient deficiencies in omega-3 fatty acids and carotenoids significantly improved Demonstrated improvements in disease progression and severity

  • Statistically significant improvements in working memory

  • Demonstrated changes in quality of life for Alzheimer's patients

  • Carers reported improvements in memory, mood, and day-to-day activities, such as getting dressed independently for the patients on the ReMind formulation compared to placebo.